1. |
Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic escherichia coli nissle 1917 is as effective as with standard mesalazine [J]. Gut, 2004, 53(11): 1617-1623.
|
2. |
中華醫學會消化病學分會炎癥性腸病協作組. 對我國炎癥性腸病診斷治療規范的共識意見[J]. 中華消化雜志, 2007, 27(8): 545-550.
|
3. |
Masseret E, Boudeau J, Colombel JF, et al. Genetically related Escherichia coli strains associated with Crohn′s disease [J]. Gut, 2001, 48(3): 320-325.
|
4. |
Fabia R, Ar′Rajab A, Johansson ML, et al. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat [J]. Digestion, 1993, 54(4): 248-255.
|
5. |
Laudanno OM, Cesolari JA, Godoy A, et al. Bioflora probiotic in immunomodulation and prophylaxis of intestinal bacterial translocation in rats[J]. Dig Dis Sci, 2008, 53(10): 2667-2670.
|
6. |
Schiffrin EJ, Blum S. Interactions between the microbiota and the intestinal mucosa [J]. Eur J Clin Nutr, 2002, 56(Suppl 3): 60-64.
|